Glucagon-like peptide-1 represents a compelling development in the loss arena . Originally designed to manage type 2 diabetes , these medications have revealed considerable ability to encourage weight reduction and enhance body fitness. Researchers actively studying their impact in addressing excess weight in patients lacking a diabetes diagnosis.